Susumu Takeuchi

M.D., Ph.D., Assistant professor

Nippon Medical School

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Susumu Takeuchi is an Assistant Professor at Nippon Medical School in Japan. His research primarily focuses on genomic profiling in advanced solid cancers, neurotrophic tropomyosin-receptor kinase inhibitors, and treatment strategies for non-small cell lung cancer. Recent publications include studies on the predictive biomarkers in lung adenocarcinomas and the role of artificial intelligence in cancer imaging data analysis.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (2)

Yasuhiro Kato

assistant professor

Nippon Medical School

JAPAN

View details

Yujin Kudo

Assistant Professor

University of Tokyo Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Susumu Takeuchi

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

A single-institution retrospective study of comprehensive genomic profiling tests based on C-CAT findings for advanced solid cancers

Induction of resistance to neurotrophic tropomyosin‐receptor kinase inhibitors by HMGCS2 via a mevalonate pathway

Osimertinib early dose reduction as a risk to brain metastasis control in EGFR‐mutant non‐small cell lung cancer

Standard versus low‐dose nab‐paclitaxel in previously treated patients with advanced non‐small cell lung cancer: A randomized phase II trial (JMTO LC14‐01)

Artificial intelligence analysis of three-dimensional imaging data derives factors associated with postoperative recurrence in patients with radiologically solid-predominant small-sized lung cancers

Multiple cancer type classification by small RNA expression profiles with plasma samples from multiple facilities

Alpha‐actinin‐4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas

Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B)

Serum-derived exosomal PD-L1 expression to predict anti-PD-1 response and in patients with non-small cell lung cancer

Evaluation of a Tool that Enables Cancer Patients to Participate in the Decision-Making Process during Treatment Selection

Lung cancer and obstructive lung disease in never smokers

Immune checkpoint inhibitor‐associated interstitial lung diseases correlate with better prognosis in patients with advanced non‐small‐cell lung cancer

Collaborators (2)

Yasuhiro Kato

Yujin Kudo

Make your next move.